Neuhauser, Magdalena <br/><br/>
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  Jul 2019 
 - 967-976 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.1080/0284186X.2019.1599137  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Austria--epidemiology<br/>Brain Neoplasms--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Prognosis<br/>Progression-Free Survival<br/>Registries--statistics & numerical data<br/>Rituximab--therapeutic use<br/>Survival Analysis<br/>Young Adult